“We are closer and a cure for pancreatic cancer will be feasible.”
Interview with Manuel Hidalgo, research associate at Peaches Biotech, in the supplement A tu Salud of La razón. Research talent is one of our company’s greatest assets. On this occasion, Manuel Hidalgo, Director of the Division of Hematology-Oncology at Weill...
Peaches Biotech is working on a new approach against pancreatic cancer.
Tribune published in El Economista Our CEO, Juan Carlos de Gregoriohas had the opportunity to publish in The Economist a forum where he shares his vision on the current treatments for pancreatic cancer, as well as the new approach proposed by Peaches against...
New biotechnology platform enables production of complex biologic drugs for allogeneic use
Combined in silico and experimental research to test the potential immunogenicity of a new complex biologic drug (PRS CK STORM). The American Journal of Biomedical Science and Research has published and endorsed a new article on our drug PRS CK STORM. You can...
Peaches Biotech publishes positive in vivo results of its drug PRS CK STORM
Peaches Biotech publishes positive in vivo results of its drug PRS CK STORM of its drug PRS CK STORM against the cytokine storm associated with infectious processes, including COVID-19. These results, published in the journal Biomedicines, refer to the in vivo...